Skip to main content
Clinical Trials/CTRI/2021/07/034616
CTRI/2021/07/034616
Not Applicable
Phase 4

Studying the role of probiotics as potential biotherapeutics for cervical intraepithelial neoplasia

BANBEIS Ministry of Education0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: N870- Mild cervical dysplasia
Sponsor
BANBEIS Ministry of Education
Status
Not Applicable
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
BANBEIS Ministry of Education

Eligibility Criteria

Inclusion Criteria

  • Age: 18 \-45 years
  • Non\-pregnant
  • Willing to take conservative treatment and colposcopy (if required)
  • Not taking antibiotics, probiotics, vitamins and other medications for any other co morbidity within one month before participating in this research work.
  • Women irrespective of their ethnicity, parity, phase in their cycle and use of contraception, Smoking, alcohol consumption habits.
  • Women with a diagnosis of LSIL on their latest PAP smear
  • Women with a first as well as with a repeat LSIL diagnosis

Exclusion Criteria

  • Age: female below 18 years and above 45 years
  • Not willing to take conservative treatment and colposcopy (if required)
  • Taking antibiotics, probiotics, vitamins and other medications for any other co morbidity within one month before participating in this research work.
  • Women with a previous history of cervical treatment
  • Women with HIV or hepatitis B/C positive with autoimmune diseases
  • Patients suffering from invasive cervical cancer

Outcomes

Primary Outcomes

Not specified

Similar Trials